Bridging Therapy With Heparin Before Starting Rivaroxaban in Ischemic Stroke or Transient Ischemic Attack With Non-Valvular Atrial Fibrillation

CONCLUSIONS: The composite of ischemic events and major bleeding was more frequent in patients with NVAF who received bridging therapy with low-dose heparin than in those who started treatment directly with rivaroxaban after ischemic stroke or TIA.PMID:34789635 | DOI:10.1253/circj.CJ-21-0617

Source: Circulation Journal - November 18, 2021 Category: Cardiology Authors: Keisuke Tokunaga Masahiro Yasaka Kazunori Toyoda Etsuro Mori Teruyuki Hirano Toshimitsu Hamasaki Hiroshi Yamagami Takehiko Nagao Shinichi Yoshimura Shinichiro Uchiyama Kazuo Minematsu RELAXED Study Investigators Source Type: research